These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3424406)

  • 1. Early adventures in drug metabolism: 4. Diphenylhydantoin (phenytoin).
    Glazko AJ
    Ther Drug Monit; 1987 Dec; 9(4):407-15. PubMed ID: 3424406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
    Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
    J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
    Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH
    Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute configuration of (+)-5-(o-hydroxyphenyl)-5-phenylhydantoin, the major metabolite of 5,5-diphenylhydantoin in the dog.
    Maguire JH; Butler TC; Dudley KH
    J Med Chem; 1978 Dec; 21(12):1294-7. PubMed ID: 722736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of 5-(p-hydroxyphenyl)-5-phenylhydantoin and studies relating to the disposition of phenytoin in man.
    Witkin KM; Bius DL; Teague BL; Wiese LS; Boyles LW; Dudley KH
    Ther Drug Monit; 1979; 1(1):11-34. PubMed ID: 553326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
    Butler TC; Dudley KH; Mitchell GN; Johnson D
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin metabolism in mice.
    Chow SA; Fischer LJ
    Drug Metab Dispos; 1982; 10(2):156-60. PubMed ID: 6124402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
    Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin: pharmacogenetic polymorphism of 4'-hydroxylation.
    Inaba T
    Pharmacol Ther; 1990; 46(3):341-7. PubMed ID: 2188267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the metabolism of 5,5-diphenylhydantoin relating principally to the stereoselectivity of the hydroxylation reactions in man and the dog.
    Butler TC; Dudley KH; Johnson D; Roberts SB
    J Pharmacol Exp Ther; 1976 Oct; 199(1):82-92. PubMed ID: 978486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
    Huang JD; Hsieh CY
    Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human.
    Thompson RM; Beghin J; Fife WK; Gerber N
    Drug Metab Dispos; 1976; 4(4):349-56. PubMed ID: 8289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of 5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin (Dihydrodiol) and quantitative studies of phenytoin metabolism in man.
    Maguire JH; Kraus BL; Butler TC; Dudley KH
    Ther Drug Monit; 1979; 1(3):359-70. PubMed ID: 555579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative estimation of catechol/methylcatechol pathways in human phenytoin metabolism.
    Maguire JH
    Epilepsia; 1988; 29(6):753-9. PubMed ID: 3191891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model describing the disposition of phenytoin in isolated rat hepatocytes.
    Morais JA; Wagner JG
    Biopharm Drug Dispos; 1984; 5(4):357-76. PubMed ID: 6525443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pregnancy on the biliary excretion of [14C]phenytoin in the rat.
    Vore M; Soliven E; Blunden M
    J Pharmacol Exp Ther; 1979 Feb; 208(2):257-62. PubMed ID: 762658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible function of astrocyte cytochrome P450 in control of xenobiotic phenytoin in the brain: in vitro studies on murine astrocyte primary cultures.
    Meyer RP; Knoth R; Schiltz E; Volk B
    Exp Neurol; 2001 Feb; 167(2):376-84. PubMed ID: 11161626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The elimination of phenytoin in man.
    Eadie MJ; Tyrer JH; Bochner F; Hooper WD
    Clin Exp Pharmacol Physiol; 1976; 3(3):217-24. PubMed ID: 975617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of p-hydroxylated and dihydrodiol metabolites of phenytoin in urine by high-performance liquid chromatography.
    Szabo GK; Pylilo RJ; Davoudi H; Browne TR
    J Chromatogr; 1990 Dec; 535(1-2):279-85. PubMed ID: 2089057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the CYP2C9 AND CYP2C19 polymorphisms on phenytoin hydroxylation in healthy individuals from south India.
    Rosemary J; Surendiran A; Rajan S; Shashindran CH; Adithan C
    Indian J Med Res; 2006 May; 123(5):665-70. PubMed ID: 16873909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.